Relmada Therapeutics Inc. (RLMD) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Relmada Therapeutics Inc.

    NASDAQ: RLMD · Real-Time Price · USD
    2.08
    -0.24 (-10.34%)
    At close: Oct 06, 2025, 3:59 PM
    2.02
    -2.88%
    After-hours: Oct 06, 2025, 04:55 PM EDT

    Relmada Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.2 -0.31 -0.16 -0.63
    PEG Ratio
    		 0.01 0.01 0.01 -0.01
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 0.44 0.36 0.18 0.38
    P/FCF Ratio
    		 -0.3 -0.6 -0.25 -0.86
    P/OCF Ratio
    		 -0.3 -0.6 -0.25 -0.86
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a n/a n/a n/a
    Quick Ratio
    		 4.45 8.00 12.26 14.83
    Current Ratio
    		 4.45 8.00 12.26 14.83
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -2.25 -1.16 -1.12 -0.6
    Return on Assets
    		 -1.75 -1.01 -1.03 -0.56
    Return on Invested Capital
    		 -2.36 -1.21 -1.15 -0.6
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist